Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer
Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the safety and efficacy of Zalutumumab alone or in
combination with Irinotecan for the treatment of patients with Colorectal Cancer